Equipment for drug release testing of medicated chewing gums

Journal of Pharmaceutical and Biomedical Analysis

Volumn 22, Issue 3, 2000, Pages 405-411

  Kvist, L Catharina ^a   Andersson, Sven Börje ^a   Berglund, Johan ^a   Wennergren, Bo ^b   Fors, Susan M ^a  

^a Pharmacia & Upjohn AB   (Sweden)

^b Odarlovs Molla Oresundsvagen 14 S   (Sweden)

Author keywords

Dimenhydrinate; Drug release testing in vitro; Equipment for gum formulations; Meclizine; Medicated gums; Nicotine; Xylitol

Indexed keywords

DIMENHYDRINATE; MECLOZINE; NICOTINE; NICOTINE GUM; TRAVELL; UNCLASSIFIED DRUG; XYLITOL;

APPARATUS; CHEWING GUM; CONFERENCE PAPER; CONTROLLED STUDY; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MASTICATION; NONHUMAN; PRIORITY JOURNAL;

ANTIEMETICS; CHEMISTRY, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHEWING GUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMENHYDRINATE; DOSAGE FORMS; EQUIPMENT DESIGN; MECLIZINE; NICOTINE; NICOTINIC AGONISTS; XYLITOL;

EID: 0034020235     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00307-6     Document Type: Conference Paper

References (11)

1. 〈1088〉 In Vitro and In Vivo Evaluation of Dosage Forms, USP 23, 1924-1929.
2. Sievert M. FIP guidelines for dissolution testing of solid oral products. Drugs Made Ger. 38(2):1995;50-61.
3. Christrup L.L., Moeller N. Arch. Pharm. Chem. Sci. Ed. 14:1986;30-36.
4. Rider J.N., Brunson E.L., Chambliss W.G., Cleary R.W., Hikal A.H., Rider P.H., Walker L.A., Wyandt C.M., Jones A.B. Pharm. Res. 9(2):1992;255-259.
5. US Patent, 5,087,424.
6. European Patent, EP 0 344 267 B.
7. Canadian Patent, 1,329,022.
8. Japanese Patent, 2679854.
9. C. Kvist, S.-B. Andersson, S. Fors, B. Wennergren, J. Berglund, Int. J. Pharm. 189 (1999) 57-65.
10. Quality Control Reports, The Gold Sheet, 29 (8) (1995) 3-8.
11. Quality Control Reports, The Gold Sheet, 26 (9) (1992) 3-4.